What Is Compass Therapeutics, Inc. (CMPX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Compass Therapeutics, Inc.'s intrinsic value is estimated at $0.87. Trading at its current price of $2.14, the valuation engine raises significant caution: 8 of 9 models flag downside risk, projecting an average implied return of -59.2%. The most optimistic model, PWERM, places fair value at $2.24 (+4.7%), while ML-RIV — the most conservative — estimates $0.18 (-91.4%). This +96.1% gap reflects genuine analytical uncertainty about Compass Therapeutics, Inc.'s intrinsic worth.
What Do the Models Say About CMPX?
9 of 13 models are currently active for CMPX. Of these, 1 model suggests upside while 8 models suggest overvaluation. The Bayesian DCF estimates CMPX's intrinsic value at $0.87, implying -59.2% downside from the current price. See which stocks rank higher →
How Does CMPX Rank in Biological Products, (No Diagnostic Substances)?
Among 134 Biological Products, (No Diagnostic Substances) stocks, CMPX ranks #55 by Quality of Company score. CirclFi's QOC score of 5.6/10 evaluates 32 fundamental signals. A score of 5.6 reflects mixed fundamentals.
See all Most Undervalued Biological Products, (No Diagnostic Substances) Stocks →
Compass Therapeutics, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is CMPX a Value Trap?
CirclFi's Value Trap algorithm assigns CMPX a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
9 of 13 models are active for Compass Therapeutics, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Compass Therapeutics, Inc. scores 5.6 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +96.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every CMPX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across CMPX's 9 active models, average confidence is 26%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad